Ethics and drug policy

Psychiatry

Volumn 6, Issue 2, 2007, Pages 59-62

  Wodak, Alex ^a  

^a ST VINCENT S HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

COST EFFECTIVENESS ANALYSIS; DEONTOLOGY; DRUG CONTROL; DRUG LEGISLATION; DRUG USE; HARM REDUCTION; HEALTH CARE POLICY; HEALTH ECONOMICS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LEGAL ASPECT; MEDICAL ETHICS; PANDEMIC; PRIORITY JOURNAL; REVIEW; SOCIAL SUPPORT;

EID: 33846781314     PISSN: 14761793     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mppsy.2007.01.001     Document Type: Review

References (16)

1. Bewley-Taylor D.R. The United States and international drug control, 1909-1997 (1999), Pinter, London and New York
2. Bruun K., Pan L., and Rexed I. The Gentlemen's Club: international control of drugs and alcohol (1975), University of Chicago Press, Chicago and London
3. Baum D. Smoke and mirrors: the war on drugs and the politics of failure (1997), Little Brown & Co, Boston, MA
4. International Harm Reduction Association. What is harm reduction?. Discussion Papers (2003), International Harm Reduction Association. http://www.ihra.net/whatisharmreduction (accessed 9 Jan 2007)
5. Drucker E. Drug prohibition and public health: 25 years of evidence. Public Health Rep 114 (1999) 14-29
6. Westermeyer J. The pro-heroin effects of anti-opium laws in Asia. Arch Gen Psychiatry 33 (1976) 1135-1139
7. United Nations Office on Drugs and Crime (UNODC). 2005 World drug report (2005), United Nations Office on Drugs and Crime, Vienna. http://www.unodc.org/unodc/world_drug_report_2005.html (accessed 17 Dec 2006)
8. Wodak A., and Cooney A. Do needle syringe programs reduce HIV infection among injecting drug users: a comprehensive review of the international evidence. Subst Use Misuse 41 (2006) 777-813
9. Buchanan D., Shaw S., Ford A., and Singer M. Empirical science meets moral panic: an analysis of the politics of needle exchange. J Public Health Policy 24 (2003) 427-444
10. Ward J., Mattick R.P., and Hall W. Key issues in methadone maintenance treatment (1992), New South Wales University Press, Sydney
11. Strategy Unit Drugs Report. Phase one - understanding the issues (May 2003). http://www.strategy.gov.uk/downloads/work_areas/drugs/drugs_report.pdf (accessed 17 Dec 2006)
12. Nadelmann E. Drug prohibition in the United States: costs, consequences and alternatives. Science (1989) 939-947
13. McCoun R., and Reuter P. Drug war heresies: learning from other vices, times and places (2001), Cambridge University Press, Cambridge
14. Boyum D., and Reuter P. Analytic assessment of US drug policy (2003), American Enterprise Institute for Public Policy Research, Washington, DC. Also available at: http://www.aei.org/publications/pubID.22192,filter.all/pub_detail.asp (accessed 17 Dec 2006)
15. Bewley-Taylor D.R. Challenging the UN drug control conventions: problems and possibilities. Int J Drug Policy 14 (2003) 171-179
16. Nadelmann E. Thinking seriously about alternatives to drug prohibition. Deadulus 121 (1992) 85-132